Terms: = Uterine cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Prognosis
9 results:
1. Mismatch repair gene
Zhou LZ; Xiao HQ; Chen J
Front Immunol; 2024; 15():1302797. PubMed ID: 38390329
[TBL] [Abstract] [Full Text] [Related]
2. Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer.
Rocha Martins P; Luciano Pereira Morais K; de Lima Galdino NA; Jacauna A; Paula SOC; Magalhães WCS; Zuccherato LW; Campos LS; Salles PGO; Gollob KJ
Sci Rep; 2023 Dec; 13(1):22634. PubMed ID: 38114557
[TBL] [Abstract] [Full Text] [Related]
3. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
[TBL] [Abstract] [Full Text] [Related]
4. Endometrial cancer-Infiltrating Mesenchymal Stem Cells Exhibit Immunosuppressive Effects.
Wang KH; Chang YH; Harnod T; Ding DC
Cell Transplant; 2022; 31():9636897221104452. PubMed ID: 35712817
[TBL] [Abstract] [Full Text] [Related]
5. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in uterine Corpus Endometrial Carcinoma.
Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
Front Immunol; 2021; 12():788431. PubMed ID: 34970268
[TBL] [Abstract] [Full Text] [Related]
6. Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.
Liu J; Nie S; Wu Z; Jiang Y; Wan Y; Li S; Meng H; Zhou S; Cheng W
Genomics; 2020 Sep; 112(5):3117-3134. PubMed ID: 32474122
[TBL] [Abstract] [Full Text] [Related]
7. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
[TBL] [Abstract] [Full Text] [Related]
8. Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
Fiano V; Trevisan M; Fasanelli F; Grasso C; Marabese F; da Graça Bicalho M; de Carvalho NS; Maestri CA; Merletti F; Sacerdote C; De Marco L; Gillio-Tos A
Gynecol Oncol; 2018 Nov; 151(2):319-326. PubMed ID: 30172480
[TBL] [Abstract] [Full Text] [Related]
9. Genomic organization of human papillomavirus type 18 in cervical cancer specimens.
Kitagawa K; Yoshikawa H; Onda T; Kawana T; Taketani Y; Yoshikura H; Iwamoto A
Jpn J Cancer Res; 1996 Mar; 87(3):263-8. PubMed ID: 8613428
[TBL] [Abstract] [Full Text] [Related]
